These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9025746)

  • 1. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi.
    Kapucu LO; Akyüz C; Vural G; Oguz A; Atasever T; Büyükpamukçu M; Unlü M
    J Nucl Med; 1997 Feb; 38(2):243-7. PubMed ID: 9025746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
    Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
    Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
    Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
    Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chemotherapy response using technetium-99M-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: a preliminary report.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Int J Cancer; 2001 Jul; 95(4):228-31. PubMed ID: 11400115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
    Koutsikos J; Athanasoulis T; Anagnostopoulos A; Velidaki A; Passadi M; Dimopoulos MA; Zerva C
    J Nucl Med; 2005 Jun; 46(6):978-82. PubMed ID: 15937309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
    Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
    J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
    Yamamoto Y; Nishiyama Y; Satoh K; Takashima H; Ohkawa M; Fujita J; Kishi T; Matsuno S; Tanabe M
    J Nucl Med; 1998 Sep; 39(9):1626-9. PubMed ID: 9744357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evaluation of pancreatic transplants using technetium-99m-sestamibi.
    Elgazzar AH; Munda R; Fernandez-Ulloa M; Clark J; Ryan JR; Hughes JA
    J Nucl Med; 1995 May; 36(5):771-7. PubMed ID: 7738646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
    Kostakoglu L; Uysal U; Ozyar E; Hayran M; Uzal D; Demirkazïk FB; Kars A; Atahan L; Bekdik CF
    J Nucl Med; 1997 Jul; 38(7):1009-14. PubMed ID: 9225780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.
    Spyridonidis TJ; Matsouka P; Symeonidis A; Savvopoulos C; Vassilakos PJ; Apostolopoulos DJ
    Clin Nucl Med; 2013 Nov; 38(11):847-54. PubMed ID: 24089060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
    Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
    J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.
    Lazarowski A; Dupont J; Fernández J; Garay G; Florín A; Solimano J; Riveros D; Cacchione R
    Lymphat Res Biol; 2006; 4(1):23-8. PubMed ID: 16569203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of scintigraphy with 99mTc-MIBI in the diagnosis and follow-up of Hodgkin's and non-Hodgkin's lymphomas].
    Solano Bravo ME; Perera Pintado A; Gómez Pérez JR; Rodríguez Pérez JL; Sánchez Mendoza EL; Pérez Valdés M; Sánchez Del Campo Romero M
    Rev Esp Med Nucl; 2000 Apr; 19(2):85-91. PubMed ID: 10799923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial perfusion scintigraphy with 99mTC-sestamibi and gated SPECT and myocardial perfusion scintigraphy with reinjection of 201Tl at 24 hours. Are the techniques comparable?].
    Fuster D; Solà M; Magriñá J; García A; Pavía J; Vidal-Sicart S; Huguet M; Muxí A
    Rev Esp Med Nucl; 1999 Jun; 18(3):169-75. PubMed ID: 10431064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.
    Koster K; Wackers FJ; Mattera JA; Fetterman RC
    J Nucl Med; 1990 Aug; 31(8):1400-8. PubMed ID: 2143529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
    Howman-Giles R; Uren RF; Shaw PJ
    J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
    Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
    J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
    Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF
    J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
    Ozcan Z; Erenel G; Aksoylar S; Kansoy S; Burak Z; Ozkiliç H
    Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.